H4497
An Act ensuring access to specialty medications
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to improve access to specialty medications for patients in Massachusetts. It seeks to address challenges related to the high cost of these medications, which are often used to treat complex or chronic conditions. The bill intends to establish a process for reviewing and potentially negotiating prices for certain specialty drugs, with the goal of making them more affordable for patients. It also seeks to ensure that patients have timely access to the medications they need.
Key provisions
- Establish a process for reviewing specialty drug prices.
- Potentially negotiate prices with pharmaceutical manufacturers.
- Improve access to specialty medications for patients.
- Address affordability challenges related to specialty drugs.
- Focus on medications used to treat complex or chronic conditions.
Who is affected
- Patients in Massachusetts
- Pharmaceutical manufacturers
- Healthcare providers
- Insurance companies
- The healthcare system in Massachusetts
Sponsors
Official sponsors from legislative records.
Primary sponsor
Joint Committee on Financial Services
Cosponsor
Danillo A. Sena
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.4497 194th (Current)
An Act ensuring access to specialty medications
View Text Print Preview Download PDF
Bill Information
Bill Information
Sponsor: Joint Committee on Financial Services Status: Referred to Joint Committee on Health Care Financing
Tabs
Bill History Cosponsors Committee Vote Committee Summary
Bill History
Displaying 5 actions for Bill H.4497
| Date | Branch | Action |
| 9/18/2025 | House | Reported from the committee on Financial Services |
| 9/18/2025 | House | New draft of H1322 |
| 9/18/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
Similar Bills
H.1322 194th (Current)
An Act ensuring access to specialty medications
HD.4324 193rd (2023 - 2024)
An Act ensuring access to specialty medications
S.777 194th (Current)
An Act relative to specialty medications and patient safety
H.1199 192nd (2021 - 2022)
An Act relative to specialty medications and patient safety
H.1144 193rd (2023 - 2024)
An Act relative to specialty medications and patient safety
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.